Oral fluid testing for pertussis, England and Wales, June 2007-August 2009

Emerging Infectious Diseases

Volumn 20, Issue 6, 2014, Pages 968-975

  Campbell, Helen ^a   Amirthalingam, Gayatri ^a   Fry, Norman K ^a   Litt, David ^a   Harrison, Timothy G ^a   Wagner, Karen ^a   Crowcroft, Natasha S ^b   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC TEST; HUMAN; INFANT; MAJOR CLINICAL STUDY; ORAL FLUID TEST; PERTUSSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; UNITED KINGDOM; BORDETELLA PERTUSSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; SALIVA; VACCINATION; WHOOPING COUGH;

PERTUSSIS VACCINE;

ADOLESCENT; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INCIDENCE; INFANT; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; SALIVA; VACCINATION; WALES; WHOOPING COUGH;

EID: 84901007339     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2006.131069     Document Type: Article

References (35)

1. Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect. 1999;123:403-11. http://dx.doi.org/10.1017/S0950268899003052
2. Clarkson JA, Fine PE. The efficiency of measles and pertussis notification in England and Wales. Int J Epidemiol. 1985;14:153-68. http://dx.doi.org/10.1093/ije/14.1.153
3. Centers for Disease Control and Prevention. 2013 provisional pertussis surveillance report. Provisional 2013 reports of notifiable diseases. 2013:62 [cited 2013 Sep 3]. http://www.cdc.gov/pertussis/ downloads/pertussis-surveillance-report.pdf
4. Public Health Agency of Canada. Pertussis [cited 2012 Jul 23]. http://www.phac-aspc.gc.ca/im/vpd-mev/pertussis-eng.php
5. Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison TG, et al. Accelerating control of pertussis in England and Wales. Emerg Infect Dis. 2012;18:38-47. http://dx.doi.org/10.3201/ eid1801.110784
6. Miller E, Fleming DM, Ashworth LA, Mabbett DA, Vurdien JE, Elliott TS. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. [Erratum in: Commun Dis Public Health 2000;3:221.] Commun Dis Public Health. 2000;3:132-4.
7. Nardone A, Pebody RG, Maple PAC, Andrews N, Gay NJ, Miller E. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine. 2004;22:1314-9. http://dx.doi.org/10.1016/ j.vaccine.2003.08.039
8. Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, Mayon-White R, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ. 2006;333:174-7. http://dx.doi.org/10.1136/bmj.38870. 655405.AE
9. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J. 2005;24(Suppl):S44-7. http:// dx.doi.org/10.1097/01.inf.0000160912.58660.87
10. Hallander HO. Microbiological and serological diagnosis of pertussis. Clin Infect Dis. 1999;28(Suppl 2):S99-106. http://dx.doi. org/10.1086/515056
11. Fry NK, Duncan J, Wagner K, Tzivra O, Doshi N, Litt DJ, et al. Role of PCR in the diagnosis of pertussis infection in infants: 5 years' experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol. 2009;58:1023-9. http://dx.doi.org/10.1099/jmm.0.009878-0
12. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis. 1996;174:89-96. http://dx.doi.org/10.1093/infdis/174.1.89
13. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain Group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011;30:307-12 http://dx.doi.org/10.1007/s10096-010-1104-y. Epub 2010 Nov 11.
14. He Q, Barkoff AM, Mertsola J, Glismann S, Bacci S; European Bordetella expert group (EU Pertstrain); European Surveillance Network for Vaccine-Preventable Diseases (EUVAC. NET). High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill. 2012;17:20239.
15. Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infant. Arch Dis Child. 2003;88:802-6. http://dx.doi.org/10.1136/adc.88.9.802
16. Litt DJ, Samuel D, Duncan J, Harnden A, George RC, Harrison TG. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J Med Microbiol. 2006;55:1223-8. http://dx.doi. org/10.1099/jmm.0.46543-0
17. Fry NK, Litt DJ, Duncan J, Vaghji L, Warrener L, Samuel D, et al. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. J Med Microbiol. 2013;62:1281-9. Epub 2013 May 30. http://dx.doi.org/10.1099/ jmm.0.062000-0
18. Manikkavasagan G, Bukasa A, Brown KE, Cohen BJ, Ramsay ME. Oral fluid testing during 10 years of rubella elimination, England and Wales. Emerg Infect Dis. 2010;16:1532-8. http://dx.doi.org/10.3201/eid1610.100560
19. Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ. 1994;308:1015-7. http://dx.doi.org/10.1136/ bmj.308.6935.1015
20. Crowcroft NS, Fry NK, Litt DJ, Harrison TG, George RC, Abid M, et al. Whooping cough-better methods of diagnosis are now available. BMJ Rapid Responses 2007 [cited 2007 June 21]. http://www.bmj.com/rapid-response/2011/11/01/whooping-cough-%E2%80%93-better-methods-diagnosis-are-now-available
21. Public Health Laboratory Service. Whooping cough: enhanced laboratory surveillance of pertussis, England and Wales 2002. CDR Weekly 2003;13:7-9.
22. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38:800-6.
23. Health Protection Agency. Laboratory-confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in 2011. Health Protection Report 2012; 6 [cited 2013 Sep 3]. http://www. hpa.org.uk/hpr/archives/2012/hpr0812.pdf
24. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child. 2013 May 22. [Epub ahead of print] http://adc.bmj. com/content/98/7/552.full.pdf+html?sid=0a6a8493-4c2b-4b58-9fc0-112e37264597
25. Department of Health. Pregnant women to be offered whooping cough vaccination UK [cited 2012 Sep 28]. http://www.dh.gov.uk/ health/2012/09/whooping-cough/
26. Centers for Disease Control and Prevention. Pertussis epidemic-Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012;61:517-22.
27. Campbell P, McIntyre P, Quinn H, Hueston L, Gilbert GL, McVernon J. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS ONE. 2012;7:e35874. Epub 2012 Apr 27. http://dx.doi.org/10.1371/journal.pone.0035874
28. Government of New Brunswick. Update/whooping cough outbreak. News release [cited 2012 Mar 26]. http://www2.gnb.ca/content/gnb/ en/news/news_release.2012.03.0255.html
29. Health and Safety Watch Inc. Update: according to Vancouver Coastal Health, pertussis activity declined significantly in the fall of 2012 [cited 2013 Jan 16]. http://www.healthandsafetywatch.com/HSWEvents. aspx?EventID=c2e8c6d3-b2d9-4b52-b594-fed31c386bbd
30. Ramsay MEB, Farrington CP, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect. 1993;111:41-8. http://dx.doi.org/10.1017/S095026880005665X
31. Philipson K, Goodyear-Smith F, Grant CC, Chong A, Turner N, Stewart J. When is acute persistent cough in school-age children and adults whooping cough? A prospective case series study. Br J Gen Pract. 2013;63:573-9. http://dx.doi.org/10.3399/bjgp13X670705
32. Public Health England. Laboratory-confirmed cases of pertussis reported to the enhanced pertussis surveillance programme during October to December 2012. Health Protection Report Vol. 7, Nos. 14-17: 5, 12, 19 and 26 April 2013 [cited 2013 Sep 9]. http://www. hpa.org.uk/hpr/archives/2013/hpr14-1713.pdf
33. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308:2126-32. http://dx.doi.org/10.1001/jama.2012.14939
34. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54:1730-5. http://dx.doi.org/10.1093/cid/cis287
35. Gabutti G, Rota MC. Pertussis: a review of disease epidemiology worldwide and in Italy. Int J Environ Res Public Health. 2012;9:4626-38. http://dx.doi.org/10.3390/ijerph9124626